GLP-1 Medications and Metabolic Health
Summary Download PDF Glucagon-like peptide-1 (GLP-1) receptor agonists represent one of the most significant pharmaceutical advances in the treatment of
Policy Brief
Reforming the U.S. Dietary Guidelines for Americans (DGA) for a Metabolically Broken Nation: A Call to Action for the Inclusion of a Low-Carbohydrate Diet
Summary Since the DGA launched in 1980, obesity rates have skyrocketed, and metabolic disease is now the norm: over 75%